{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:47:57Z","timestamp":1780472877616,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Hilfe f\u00fcr das rheumakranke Kind e.V."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0228-y","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T19:30:29Z","timestamp":1518463829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing \u2013 treatment protocol and preliminary results"],"prefix":"10.1186","volume":"16","author":[{"given":"Lea","family":"H\u00f6fel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Storf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Schn\u00f6bel-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-6719","authenticated-orcid":false,"given":"Boris","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"228_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63:465\u201382.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"228_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli A, Davi S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP, Lattanzi B, Filocamo G, Verazza S, Gerloni V, et al. Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Lancet. 2017;389:909\u201316.","journal-title":"Lancet"},{"key":"228_CR3","first-page":"2501","volume":"31","author":"O Ortiz-Alvarez","year":"2004","unstructured":"Ortiz-Alvarez O, Morishita K, Avery G, Green J, Petty RE, Tucker LB, Malleson PN, Cabral DA. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis. J Rheumatol. 2004;31:2501\u20136.","journal-title":"J Rheumatol"},{"key":"228_CR4","first-page":"480","volume":"25","author":"A van der Meer","year":"2007","unstructured":"van der Meer A, Wulffraat NM, Prakken BJ, Gijsbers B, Rademaker CM, Sinnema G. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study. Clin Exp Rheumatol. 2007;25:480\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"228_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12969-016-0071-y","volume":"14","author":"A Scheuern","year":"2016","unstructured":"Scheuern A, Fischer N, McDonald J, Brunner HI, Haas JP, Hugle B. Mutations in the MTHFR gene are not associated with methotrexate intolerance in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14:11.","journal-title":"Pediatr Rheumatol Online J"},{"key":"228_CR6","doi-asserted-by":"crossref","unstructured":"Scheuern A, Tyrrell PN, Haas JP, Hugle B. Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effect. Rheumatology (Oxford). 2017;","DOI":"10.1093\/rheumatology\/kew507"},{"key":"228_CR7","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/art.30367","volume":"63","author":"M Bulatovic","year":"2011","unstructured":"Bulatovic M, Heijstek MW, Verkaaik M, van Dijkhuizen EH, Armbrust W, Hoppenreijs EP, Kamphuis S, Kuis W, Egberts TC, Sinnema G, et al. High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score. Arthritis Rheum. 2011;63:2007\u201313.","journal-title":"Arthritis Rheum"},{"key":"228_CR8","first-page":"148","volume":"34","author":"EH van Dijkhuizen","year":"2016","unstructured":"van Dijkhuizen EH, Pouw JN, Scheuern A, Hugle B, Hardt S, Ganser G, Kummerle-Deschner JB, Horneff G, Holzinger D, Bulatovic Calasan M, Wulffraat NM. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study. Clin Exp Rheumatol. 2016;34:148\u201354.","journal-title":"Clin Exp Rheumatol"},{"key":"228_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-2125.2011.04054.x","volume":"73","author":"L Holmboe","year":"2012","unstructured":"Holmboe L, Andersen AM, Morkrid L, Slordal L, Hall KS. High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients. Br J Clin Pharmacol. 2012;73:106\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"228_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7812\/TPP\/13-098","volume":"18","author":"F Shapiro","year":"2014","unstructured":"Shapiro F. The role of eye movement desensitization and reprocessing (EMDR) therapy in medicine: addressing the psychological and physical symptoms stemming from adverse life experiences. Perm J. 2014;18:71\u20137.","journal-title":"Perm J"},{"key":"228_CR11","doi-asserted-by":"publisher","DOI":"10.3402\/ejpt.v7.30123","volume":"7","author":"E Dautovic","year":"2016","unstructured":"Dautovic E, de Roos C, van Rood Y, Dommerholt A, Rodenburg R. Pediatric seizure-related posttraumatic stress and anxiety symptoms treated with EMDR: a case series. Eur J Psychotraumatol. 2016;7:30123.","journal-title":"Eur J Psychotraumatol"},{"key":"228_CR12","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1111\/jan.12985","volume":"72","author":"M Maroufi","year":"2016","unstructured":"Maroufi M, Zamani S, Izadikhah Z, Marofi M, O'Connor P. Investigating the effect of eye movement desensitization and reprocessing (EMDR) on postoperative pain intensity in adolescents undergoing surgery: a randomized controlled trial. J Adv Nurs. 2016;72:2207\u201317.","journal-title":"J Adv Nurs"},{"key":"228_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/15374416.2016.1220309","volume":"46","author":"S Dorsey","year":"2017","unstructured":"Dorsey S, McLaughlin KA, Kerns SEU, Harrison JP, Lambert HK, Briggs EC, Revillion Cox J, Amaya-Jackson L. Evidence base update for psychosocial treatments for children and adolescents exposed to traumatic events. J Clin Child Adolesc Psychol. 2017;46:303\u201330.","journal-title":"J Clin Child Adolesc Psychol"},{"key":"228_CR14","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"228_CR15","doi-asserted-by":"crossref","DOI":"10.1891\/9780826131171","volume-title":"A guide to standard EMDR Therapy Protocols for Clinicians, Supervisors, and Consultants. 2nd edition edn","author":"AM Leeds","year":"2016","unstructured":"Leeds AM. A guide to standard EMDR Therapy Protocols for Clinicians, Supervisors, and Consultants. 2nd edition edn. New York: Springer Publishing Company; 2016."},{"key":"228_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","volume":"37","author":"JW Varni","year":"1999","unstructured":"Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126\u201339.","journal-title":"Med Care"},{"key":"228_CR17","volume":"10","author":"D Gillies","year":"2016","unstructured":"Gillies D, Maiocchi L, Bhandari AP, Taylor F, Gray C, O'Brien L. Psychological therapies for children and adolescents exposed to trauma. Cochrane Database Syst Rev. 2016;10:CD012371.","journal-title":"Cochrane Database Syst Rev"},{"key":"228_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.cpr.2009.06.008","volume":"29","author":"R Rodenburg","year":"2009","unstructured":"Rodenburg R, Benjamin A, de Roos C, Meijer AM, Stams GJ. Efficacy of EMDR in children: a meta-analysis. Clin Psychol Rev. 2009;29:599\u2013606.","journal-title":"Clin Psychol Rev"},{"key":"228_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1176\/appi.ajp.162.2.214","volume":"162","author":"R Bradley","year":"2005","unstructured":"Bradley R, Greene J, Russ E, Dutra L, Westen D. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162:214\u201327.","journal-title":"Am J Psychiatry"},{"key":"228_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jclp.1126","volume":"58","author":"F Shapiro","year":"2002","unstructured":"Shapiro F. EMDR 12 years after its introduction: past and future research. J Clin Psychol. 2002;58:1\u201322.","journal-title":"J Clin Psychol"},{"key":"228_CR21","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3389\/fpsyg.2017.01578","volume":"8","author":"M Hase","year":"2017","unstructured":"Hase M, Balmaceda UM, Ostacoli L, Liebermann P, Hofmann A. The AIP model of EMDR therapy and pathogenic memories. Front Psychol. 2017;8:1578.","journal-title":"Front Psychol"},{"key":"228_CR22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"Association AP","year":"2013","unstructured":"Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. DC: Washington; 2013.","edition":"5"},{"key":"228_CR23","doi-asserted-by":"crossref","unstructured":"Hugle B, Scheuern A, Dollinger S, Fischer N, Haas JP. Cathechol-O-methyltransferase Val158Met polymorphism is associated with nocebo effects, but not with methotrexate intolerance in patients with juvenile idiopathic arthritis. Scand J Rheumatol. 2017:1\u20132.","DOI":"10.1080\/03009742.2016.1275775"},{"key":"228_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-015-0002-3","volume":"13","author":"EH van Dijkhuizen","year":"2015","unstructured":"van Dijkhuizen EH, Bulatovic Calasan M, Pluijm SM, de Rotte MC, Vastert SJ, Kamphuis S, de Jonge R, Wulffraat NM. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. Pediatr Rheumatol Online J. 2015;13:5.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0228-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T17:28:46Z","timestamp":1570728526000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0228-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0228-y","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"21 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent was obtained from the parents prior to inclusion in the study. The study was approved by the ethics committee of the Medical Faculty of the Ludwig-Maximilian University, Munich, Germany (Project number 17\u2013076).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No individual patient data is reported in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are not aware of any conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"11"}}